In the US, Humira (adalimumab systemic) is a member of the following drug classes: antirheumatics, TNF alfa inhibitors and is used to treat Ankylosing Spondylitis, Crohn's Disease, Crohn's Disease - Acute, Crohn's Disease - Maintenance, Hidradenitis Suppurativa, Juvenile Idiopathic Arthritis, Plaque Psoriasis, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis and Uveitis.
US matches:
- Humira
- Humira Pediatric Crohns Start
- Humira Pen
- Humira Pen-CD/UC/HS Starter
- Humira Pen-Ps/UV Starter
Ingredient matches for Humira
Adalimumab
Adalimumab is reported as an ingredient of Humira in the following countries:
- Argentina
- Australia
- Belgium
- Bosnia & Herzegowina
- Brazil
- Canada
- Chile
- China
- Colombia
- Croatia (Hrvatska)
- Cyprus
- Czech Republic
- Denmark
- Ecuador
- Egypt
- Estonia
- Finland
- France
- Germany
- Greece
- Hong Kong
- Iceland
- Ireland
- Italy
- Japan
- Latvia
- Lebanon
- Lithuania
- Macedonia
- Mexico
- New Zealand
- Norway
- Oman
- Paraguay
- Peru
- Poland
- Portugal
- Romania
- Serbia
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Sweden
- Taiwan
- Tunisia
- Turkey
- United Kingdom
- United States
- Uruguay
- Venezuela
- Vietnam